Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995–2011
…, A Plevneshi, R Devlin, J Downey, K Katz, I Kitai… - Vaccine, 2013 - Elsevier
Background In 1995, a publicly funded pneumococcal vaccination program for 23-valent
polysaccharide vaccine (PPV23) was introduced in Ontario. Conjugate vaccines were …
polysaccharide vaccine (PPV23) was introduced in Ontario. Conjugate vaccines were …
A population-based study of tuberculosis in children and adolescents in Ontario
W Phongsamart, I Kitai, M Gardam… - The Pediatric …, 2009 - journals.lww.com
Background: There are few population-based data on presentation and treatment of
tuberculosis (TB) in children and adolescents in Ontario. Methods: We analyzed data from 121 …
tuberculosis (TB) in children and adolescents in Ontario. Methods: We analyzed data from 121 …
Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area
…, M Avendano, P Derkach, IE Ephtimios, I Kitai… - Jama, 2003 - jamanetwork.com
ContextSevere acute respiratory syndrome (SARS) is an emerging infectious disease that
first manifested in humans in China in November 2002 and has subsequently spread …
first manifested in humans in China in November 2002 and has subsequently spread …
Relating tuberculosis (TB) contact characteristics to QuantiFERON-TB-Gold and tuberculin skin test results in the Toronto pediatric TB clinic
…, D Stephens, W Pongsamart, I Kitai - Journal of the …, 2015 - academic.oup.com
Background Few data relate interferon-γ-release-assay results in children to source case
sputum status, the best predictor of infectiousness of tuberculosis (TB) patients. We evaluated …
sputum status, the best predictor of infectiousness of tuberculosis (TB) patients. We evaluated …
Invasive pneumococcal disease among immunocompromised persons: implications for vaccination programs
…, WL Gold, J Johnstone, I Kitai… - Clinical Infectious …, 2016 - academic.oup.com
Background. In 2012/2013, a single dose of 13-valent pneumococcal conjugate vaccine (PCV13)
was recommended for immunocompromised adults in the United States and Canada. …
was recommended for immunocompromised adults in the United States and Canada. …
Children hospitalized with severe acute respiratory syndrome-related illness in Toronto
…, MA Opavsky, EL Ford-Jones, A Matlow, I Kitai… - …, 2003 - publications.aap.org
Objective. An outbreak of severe acute respiratory syndrome (SARS) occurred in the greater
Toronto area between February and June 2003. We describe the clinical, laboratory, and …
Toronto area between February and June 2003. We describe the clinical, laboratory, and …
Tuberculosis: evidence review for newly arriving immigrants and refugees
C Greenaway, A Sandoe, B Vissandjee, I Kitai… - Cmaj, 2011 - Can Med Assoc
Background: The foreign-born population bears a disproportionate health burden from
tuberculosis, with a rate of active tuberculosis 20 times that of the non-Aboriginal Canadian-born …
tuberculosis, with a rate of active tuberculosis 20 times that of the non-Aboriginal Canadian-born …
Impact of the COVID-19 pandemic on the provision of routine childhood immunizations in Ontario, Canada
Background The COVID-19 pandemic has a worldwide impact on all health services, including
childhood immunizations. In Canada, there is limited data to quantify and characterize …
childhood immunizations. In Canada, there is limited data to quantify and characterize …
Strokes among black people in Harare, Zimbabwe: results of computed tomography and associated risk factors.
J Matenga, I Kitai, L Levy - Br Med J (Clin Res Ed), 1986 - bmj.com
Computed tomography was performed and risk factors evaluated in 100 consecutive adult
patients presenting to the two teaching hospitals in Harare with a clinical diagnosis of stroke. …
patients presenting to the two teaching hospitals in Harare with a clinical diagnosis of stroke. …
Drug-resistant tuberculosis: pediatric guidelines
Drug-resistant Mycobacterium tuberculosis (TB) infection represents a serious and growing
problem. For patients infected or suspected of being infected with multidrug or extensively …
problem. For patients infected or suspected of being infected with multidrug or extensively …